Open-Label Safety and PK Study of ER Hydromorphone Tablets in Opioid-Tolerant Pediatric Chronic Pain Patients

PHASE3TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 11, 2017

Primary Completion Date

February 4, 2019

Study Completion Date

February 4, 2019

Conditions

Chronic Pain

Interventions

DRUG

Hydromorphone HCl ER Tablets

Hydromorphone hydrochloride (HCl) extended release tablet

Trial Locations (3)

Jackson Memorial Hospital, University of Miami, Miami

Medical Professional Clinical Research, Miami

Clinical Pharmacology Services, Inc., Tampa